Label: LIDOCAN VII- lidocaine 5% patch

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated December 9, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Lidocan™ VII is comprised of an adhesive material containing 5% lidocaine, which is applied to a non-woven polyester felt backing and covered with a polyethylene terephthalate (PET) film release ...
  • CLINICAL PHARMACOLOGY
    Pharmacodynamics - Lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction ...
  • CLINICAL STUDIES
    Single-dose treatment with lidocaine patch 5% was compared to treatment with vehicle patch (without lidocaine), and to no treatment (observation only) in a double-blind, crossover clinical trial ...
  • INDICATIONS AND USAGE
    Lidocan™ VII is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.
  • CONTRAINDICATIONS
    Lidocan™ VII is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.
  • WARNINGS
    Risk of Methemoglobinemia - Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with ...
  • PRECAUTIONS
    General - Hepatic Disease - Patients with severe hepatic disease are at greater risk of developing toxic blood concentrations of lidocaine, because of their inability to metabolize lidocaine ...
  • ADVERSE REACTIONS
    Application Site Reactions - During or immediately after treatment with - Lidocan™ VII, the skin at the site of application may develop blisters, bruising, burning sensation, depigmentation ...
  • OVERDOSAGE
    Lidocaine overdose from cutaneous absorption is rare, but could occur. If there is any suspicion of lidocaine overdose (see ADVERSE REACTIONS, Systemic Reactions), drug blood concentration should ...
  • DOSAGE AND ADMINISTRATION
    Apply - Lidocan™ VII to intact skin to cover the most painful area. Apply the prescribed number of patches (maximum of 3), only once for up to 12 hours within a 24-hour period. Patches may be cut ...
  • HANDLING AND DISPOSAL
    Hands should be washed after the handling of - Lidocan™ VII, and eye contact with - Lidocan™ VII should be avoided. Do not store patch outside the sealed envelope. Apply immediately after ...
  • HOW SUPPLIED
    Lidocan™ VII is available as the following: Package of 30 patches.................................................................................... NDC 59088-900-54 - (packaged into ...
  • Lidocan™ VII
    Label
  • INGREDIENTS AND APPEARANCE
    Product Information